Furthermore, our results demonstrated that inhibition of ERK1/2 activity by PD98059 in hypertensive rats significantly reduced the erk2 mRNA expression, inhibited ERK1/2 phosphorylation and ameliorated the hypertension-induced vascular alterations. This evidence concerns the gene MAPK3 and hypertensive disorder.